In the Spy vs. Spy-like game of catching the athletes using illegal performance-enhancing substances, Dr. Don Catlin, chief executive of Anti-Doping Research in Los Angeles, and the former head of UCLA Olympic Analytical Labs, is among the world's foremost authorities on drug testing. He speaks with host Dr. Gary Kohn about the TE ratio marker as an indicator for pharmaceutical testosterone use, and a finding that may provide some genetically gifted individuals a license to cheat.
Drugs and Sports: Can Genes Outwit Testing?
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
In the Spy vs. Spy-like game of catching the athletes using illegal performance-enhancing substances, Dr. Don Catlin, chief executive of Anti-Doping Research in Los Angeles, and the former head of UCLA Olympic Analytical Labs, is among the world's foremost authorities on drug testing. He speaks with host Dr. Gary Kohn about the TE ratio marker as an indicator for pharmaceutical testosterone use, and a finding that may provide some genetically gifted individuals a license to cheat.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE Broadcast Replay
Love Story: Lipid Education for Women’s Heart Health
0.50 credits
<p>Love Story: Lipid Education for Women’s Heart Health</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
CME/CE
Impact of Barostim on Heart Failure Hospitalization
<p>Impact of Barostim on Heart Failure Hospitalization</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
MinuteCE®
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
1.00 credits
<p>How Do We Translate Real-World AF Data Into Everyday Clinical Practice?</p>
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
<p>Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF</p>
Cardiology
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
<p>Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial </p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?